Nuvectis Pharma, Inc. (NVCT) stock
NVCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$19.11−1.13 (-5.58%)
Close on Nov 16, 2026Market cap $622.63MP/E –Yield 0.00%
Nuvectis Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Nuvectis Pharma's enterprise value was $538.43M on Nov 11, 2026, against $124.55M a year earlier. Over the last 5 years it ranged from $25.21M to $584.61M, with a median of $129.84M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $538.43M | +240.5% |
| 2025 | Dec 31, 2025 | $158.14M | +84.9% |
| 2024 | Dec 31, 2024 | $85.54M | -30.1% |
| 2023 | Dec 29, 2023 | $122.31M | +41.9% |
| 2022 | Dec 30, 2022 | $86.18M | – |
See a number that looks wrong?